- Home
- SGHT vs BMN Comparison
SGHT vs BMN Comparison
Compare SGHT & BMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHT
- BMN
- Stock Information
- Founded
- SGHT 2011
- BMN 2020
- Country
- SGHT United States
- BMN United States
- Employees
- SGHT N/A
- BMN 19800
- Industry
- SGHT Medical Specialities
- BMN Trusts Except Educational Religious and Charitable
- Sector
- SGHT Health Care
- BMN Finance
- Exchange
- SGHT Nasdaq
- BMN Nasdaq
- Market Cap
- SGHT 140.1M
- BMN 156.0M
- IPO Year
- SGHT 2021
- BMN N/A
- Fundamental
- Price
- SGHT $2.53
- BMN $25.45
- Analyst Decision
- SGHT Buy
- BMN
- Analyst Count
- SGHT 7
- BMN 0
- Target Price
- SGHT $4.68
- BMN N/A
- AVG Volume (30 Days)
- SGHT 195.9K
- BMN 29.9K
- Earning Date
- SGHT 03-05-2025
- BMN 01-01-0001
- Dividend Yield
- SGHT N/A
- BMN 4.66%
- EPS Growth
- SGHT N/A
- BMN N/A
- EPS
- SGHT N/A
- BMN N/A
- Revenue
- SGHT $79,543,000.00
- BMN N/A
- Revenue This Year
- SGHT $1.23
- BMN N/A
- Revenue Next Year
- SGHT $0.34
- BMN N/A
- P/E Ratio
- SGHT N/A
- BMN N/A
- Revenue Growth
- SGHT N/A
- BMN N/A
- 52 Week Low
- SGHT $2.50
- BMN $21.51
- 52 Week High
- SGHT $8.45
- BMN $25.59
- Technical
- Relative Strength Index (RSI)
- SGHT 35.62
- BMN 51.05
- Support Level
- SGHT $2.59
- BMN $25.26
- Resistance Level
- SGHT $2.87
- BMN $25.50
- Average True Range (ATR)
- SGHT 0.18
- BMN 0.30
- MACD
- SGHT 0.02
- BMN -0.00
- Stochastic Oscillator
- SGHT 6.74
- BMN 31.18
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
About BMN BlackRock 2037 Municipal Target Term Trust of Beneficial Interest
BlackRock 2037 Mun Tgt is a non-diversified, closed-end management investment company. The Trust's investment objective is to provide current income that is exempt from regular federal income tax. The Trust invests in investment grade quality securities or securities that are unrated but judged to be of comparable quality by the investment adviser.